Skip to main content

Table 5 Antibiotic Susceptibility Patterns of Uropathogens in the MIST Study

From: Urinary tract infections in pregnancy in a rural population of Bangladesh: population-based prevalence, risk factors, etiology, and antibiotic resistance

 

Escherichia coli

Klebsiella species

Staphylococcus aureus

Staph species (non-aureus)

Group B Strep

Beta-hemolytic Streptococcus

Cefixime

82/119a (68.9%)

34/36 (94.4%)

0/7

4/28 (14.3%)

4/7 (57.1%)

11/11 (100.0%)

Nitrofurantoin

117/118 (99.2%)

26/35 (74.3%)

7/7 (100.0%)

28/28 (100.0%)

7/7 (100.0%)

11/11 (100.0%)

Ampicillin

40/119 (33.6%)

3/36 (8.3%)

3/7 (42.9%)

16/28 (57.1%)

7/7 (100.0%)

10/11 (90.9%)

Azithromycin

34/120 (28.3%)

3/36 (8.3%)

3/7 (42.9%)

22/28 (78.6%)

2/7 (28.6%)

6/11 (54.5%)

Cotrimoxazole

74/118 (62.7%)

35/36 (97.2%)

6/7 (85.7%)

23.28 (82.1%)

7/7 (100.0%)

11/11 (100.0%)

Gentamicin

97/117 (82.9%)

33/36 (91.7%)

6/7 (85.7%)

24/28 (85.7%)

3/7 (42.9%)

2/7 (18.2%)

Nalidixic acid

45/121 (37.2%)

33/36 (91.7%)

0/7 (0.0%)

5/28 (17.9%)

0/7 (0.0%)

0/11 (0.0%)

Cetriaxone

83/117 (70.9%)

31/35 (88.6%)

5/7 (71.4%)

24/25 (96.0%)

7/7 (100.0%)

11/11 (100.0%)

Cephalexin

74/119 (62.2%)

29/36 (80.6%)

6/7 (85.7%)

26/28 (92.9%)

5/7 (71.4%)

11/711 (100.0%)

  1. an/N in each cell report the (number of bacterial isolates susceptible to the specified antibiotic)/(number of urine samples with bacterial species isolated)